Repression of p15INK4b expression by Myc through association with Miz-1

Nature Cell Biology

Volumn 3, Issue 4, 2001, Pages 392-399

  Staller, Peter ^a   Peukert, Karen ^a   Kiermaier, Astrid ^a   Seoane, Joan ^b   Lukas, Jiri ^c   Karsunky, Holger ^d   Möröy, Tarik ^d   Bartek, Jiri ^c   Massagué, Joan ^b   Hänel, Frank ^e   Eilers, Martin ^a  

^a Institute of Molecular Biology and Tumor Research IMT   (Germany)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c Institute of Cancer Biology   (Denmark)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

^e HANS KNÖLL INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; MESSENGER RNA; MYC PROTEIN; PROTEIN P15; TRANSCRIPTION FACTOR; ZINC FINGER PROTEIN; CARRIER PROTEIN; CDKN2B PROTEIN, HUMAN; CDKN2B PROTEIN, MOUSE; CDKN2B PROTEIN, RAT; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2B; DNA BINDING PROTEIN; HYBRID PROTEIN; NUCLEAR PROTEIN; PROTEIN P16INK4A; TRANSACTIVATOR PROTEIN; TUMOR SUPPRESSOR PROTEIN; ZBTB17 PROTEIN, HUMAN;

ALLELE; ARTICLE; CELL CYCLE G1 PHASE; CELL IMMORTALIZATION; CELL LINE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME INHIBITION; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; ONCOGENE C MYB; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; TRANSACTIVATION; ANIMAL; BIOSYNTHESIS; CELL STRAIN 3T3; GENE EXPRESSION REGULATION; GENETICS; HELA CELL; METABOLISM; MOUSE; RAT;

3T3 CELLS; ANIMALS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; MICE; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-MYC; RATS; RECOMBINANT FUSION PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; ZINC FINGERS;

EID: 0034744957     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/35070076     Document Type: Article

References (47)

1. The Myc/Max/Mad network and the transcriptional control of cell behavior
2. Gene-target recognition among members of the Myc superfamily and implications for oncogenesis
3. Expression analysis with oligonucleotide microarrays reveals that Myc regulates genes involved in growth, cell cycle, signaling, and adhesion
4. Reciprocal regulation of adipogenesis by Myc and C/EBPα
5. Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-Myc
6. Myc downregulation by transforming growth factor required for activation of the p15Ink4b G1 arrest pathway
7. Cip1 by c-Myc in overcoming transforming growth factor β-induced cell-cycle arrest Proc.
8. C-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II
9. An alternative pathway for gene regulation by Myc
10. Destruction of Myc by ubiquitin-mediated proteolysis: Cancer-associated and transforming mutations stabilize Myc
11. A biomarker that identifies senescent human cells in culture and in aging skin in vivo
12. HPV16 E7 oncoprotein deregulates B-myb expression: Correlation with targeting of p107/E2F complexes
13. 1 cyclin complexes
14. Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts
15. A modified oestrogen receptor ligand binding domain as an improved switch for the regulation of heterologous proteins
16. INK4B through an Sp1 consensus site
17. C-Myc target gene specificity is determined by a post-DNA binding mechanism
18. INK4B
19. Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity
20. Discrimination between different E-box binding proteins at an endogenous target gene of Myc
21. INK4b)
22. Involvement of the Ink4 proteins p16 and p15 in T-lymphocyte senescence 17
23. INK4b genes
24. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice
25. Cyclin E-induced S phase without activation of the pRb/E2F pathway
26. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
27. Myc activates telomerase
28. Direct activation of TERT transcription by c-MYC
29. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation
30. ARF
31. ARF act in overlapping pathways in cellular immortalization
32. INK4a and of hypophosphorylated retinoblastoma family proteins
33. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins
34. INK4a characterize the major types of hematological malignancies
35. INK4b is a potential effector of cell cycle arrest mediated by TGF-β
36. Smad2, smad3 and smad4 cooperate with Sp1 to induce p15 (Ink4B) transcription in response to TGF-β
37. INK4b
38. Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor β
39. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line
40. Direct induction of cyclin D2 by Myc contributes to cell cycle induction and sequestration of p27
41. High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein
42. Identification of a Myc-dependent step during the formation of active G1 cyclin/CDK complexes
43. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumor cell lines
44. Transcriptional activation by Myc is under negative control by the transcription factor AP-2
45. Studies on the interaction of the human c-Myc protein with cell nuclei: P62 c-Myc as a member of a discrete subset of nuclear proteins
46. OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways
47. C-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points